2024-515078-28-00招募中1 期
A phase 1, open-label trial in healthy subjects and in subjects with diabetes investigating pharmacokinetics, tolerability, safety, and food effect following single and multiple dosing of danegaptide
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 56
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CEO
Scientific
Breye Therapeutics ApS
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Phase I, open label trial in healthy subjects to evaluate the central nervous receptor occupancy of pipamperone at the 5-HT2A and D2 receptor by means of Positron Emission Tomography.major depressive disorder10027946depressionNL-OMON34843PharmaNeuroBoost NV10
暂停
1 期
Drug interaction assessment of GSK3882347 in healthy participants aged 18 to 65 yearsHealthy volunteer drug interaction studyISRCTN16147016GlaxoSmithKline (United Kingdom)30
已完成
不适用
A phase I, open label clinical trial in healthy volunteers, to assess and characterize the effect of FIRTECH infrared patch on tissue perfusion, oxygenation and local microcirculation.muscle strainNL-OMON50771Sanofi Aventis Groupe20
已完成
1 期
A Trial in Healthy Participants to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRAX-944Essential TremorNeurological - Other neurological disordersACTRN12620000675921Praxis Precision Medicines24
已完成
不适用
A phase I open-label clinical trial, evaluating the therapeutic vaccine hVEGF26-104/RFASE in patients with advanced solid tumorsadvanced cancerAdvanced solid tumor10027655NL-OMON47883Vrije Universiteit Medisch Centrum27